
Tami John, MD, a clinical associate professor at Stanford Medicine, emphasized the need to build community among patients with TDT.

Tami John, MD, a clinical associate professor at Stanford Medicine, emphasized the need to build community among patients with TDT.

Tami John, MD, a clinical associate professor at Stanford Medicine, discussed considerations for using beti-cel and exa-cel for TDT in the clinic.

Tami John, MD, a clinical associate professor at Stanford Medicine, also provided background about the current state of care in TDT.

The clinical associate professor at Stanford Medicine emphasized the need to build community among patients with TDT.

The clinical associate professor at Stanford Medicine discussed considerations for using beti-cel and exa-cel for TDT in the clinic.

The clinical associate professor at Stanford Medicine also provided background about the current state of care in TDT.

The clinical associate professor at Stanford Medicine also discussed ongoing trends in sickle cell disease research.

The clinical associate professor at Stanford Medicine discussed new research on patients who have received HCT or gene therapy for SCD.